GCP
ALXN

GSA Capital Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

GSA Capital Partners’s Portfolio ALXN Stock Details ALXN Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,982
Closed -$537K – 1299
2020
Q1 		$537K Sell
5,982
-4,230
-41% -$380K 0.13% 138
2019
Q4 		$1.1M Sell
10,212
-6,388
-38% -$691K 0.13% 170
2019
Q3 		$1.63M Buy
+16,600
New +$1.63M 0.22% 41
2019
Q1 		– Sell
-43,500
Closed -$4.24M – 1786
2018
Q4 		$4.24M Buy
+43,500
New +$4.24M 0.49% 13
2018
Q3 		– Sell
-2,203
Closed -$274K – 2014
2018
Q2 		$274K Sell
2,203
-12,977
-85% -$1.61M 0.01% 1413
2018
Q1 		$1.69M Buy
+15,180
New +$1.69M 0.09% 368
2017
Q4 		– Sell
-3,836
Closed -$538K – 1917
2017
Q3 		$538K Buy
3,836
+1,482
+63% +$208K 0.04% 921
2017
Q2 		$286K Sell
2,354
-37,209
-94% -$4.52M 0.02% 1302
2017
Q1 		$4.8M Buy
39,563
+37,872
+2,240% +$4.59M 0.26% 19
2016
Q4 		$207K Sell
1,691
-16,591
-91% -$2.03M 0.01% 1582
2016
Q3 		$2.24M Buy
18,282
+5,090
+39% +$624K 0.12% 203
2016
Q2 		$1.54M Buy
13,192
+1,038
+9% +$121K 0.09% 367
2016
Q1 		$1.69M Buy
12,154
+4,955
+69% +$690K 0.11% 256
2015
Q4 		$1.37M Sell
7,199
-46,636
-87% -$8.89M 0.07% 475
2015
Q3 		$8.42M Buy
53,835
+50,750
+1,645% +$7.94M 0.41% 16
2015
Q2 		$558K Sell
3,085
-18,204
-86% -$3.29M 0.02% 1283
2015
Q1 		$3.69M Buy
21,289
+4,139
+24% +$717K 0.15% 102
2014
Q4 		$3.17M Buy
17,150
+4,062
+31% +$752K 0.22% 47
2014
Q3 		$2.17M Sell
13,088
-79,907
-86% -$13.2M 0.11% 176
2014
Q2 		$14.5M Buy
92,995
+75,127
+420% +$11.7M 0.65% 6
2014
Q1 		$2.72M Buy
+17,868
New +$2.72M 0.19% 99